NO329071B1 - Faste, hurtig desintegrerende cetirizin-formuleringer - Google Patents

Faste, hurtig desintegrerende cetirizin-formuleringer Download PDF

Info

Publication number
NO329071B1
NO329071B1 NO20004722A NO20004722A NO329071B1 NO 329071 B1 NO329071 B1 NO 329071B1 NO 20004722 A NO20004722 A NO 20004722A NO 20004722 A NO20004722 A NO 20004722A NO 329071 B1 NO329071 B1 NO 329071B1
Authority
NO
Norway
Prior art keywords
soda
formulations according
acid
base
cetirizine
Prior art date
Application number
NO20004722A
Other languages
English (en)
Norwegian (no)
Other versions
NO20004722L (no
NO20004722D0 (no
Inventor
Wolfram Tritthart
Mario Andr Piskernig
Original Assignee
Meda Pharma Gmbh & Co Kg
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Meda Pharma Gmbh & Co Kg filed Critical Meda Pharma Gmbh & Co Kg
Publication of NO20004722L publication Critical patent/NO20004722L/no
Publication of NO20004722D0 publication Critical patent/NO20004722D0/no
Publication of NO329071B1 publication Critical patent/NO329071B1/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/06—Anti-spasmodics, e.g. drugs for colics, esophagic dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Pain & Pain Management (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pulmonology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Cephalosporin Compounds (AREA)
NO20004722A 1998-03-31 2000-09-21 Faste, hurtig desintegrerende cetirizin-formuleringer NO329071B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19814256A DE19814256A1 (de) 1998-03-31 1998-03-31 Feste, schnellzerfallende Cetirizin-Formulierungen
PCT/DE1999/000799 WO1999049843A1 (de) 1998-03-31 1999-03-20 Feste, schnellzerfallende cetirizin-formulierungen

Publications (3)

Publication Number Publication Date
NO20004722L NO20004722L (no) 2000-09-21
NO20004722D0 NO20004722D0 (no) 2000-09-21
NO329071B1 true NO329071B1 (no) 2010-08-16

Family

ID=7863014

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20004722A NO329071B1 (no) 1998-03-31 2000-09-21 Faste, hurtig desintegrerende cetirizin-formuleringer

Country Status (30)

Country Link
US (1) US6245353B1 (cs)
EP (1) EP1067904B1 (cs)
JP (1) JP2002509873A (cs)
KR (1) KR100653568B1 (cs)
CN (1) CN1136838C (cs)
AR (1) AR018828A1 (cs)
AT (1) ATE209899T1 (cs)
AU (1) AU750140B2 (cs)
BG (1) BG64741B1 (cs)
BR (1) BR9909233A (cs)
CA (1) CA2326809C (cs)
CY (1) CY1107331T1 (cs)
CZ (1) CZ300704B6 (cs)
DE (2) DE19814256A1 (cs)
DK (1) DK1067904T3 (cs)
ES (1) ES2168013T3 (cs)
HU (1) HU227477B1 (cs)
IL (1) IL138606A (cs)
NO (1) NO329071B1 (cs)
NZ (1) NZ506988A (cs)
PL (1) PL191266B1 (cs)
PT (1) PT1067904E (cs)
RU (1) RU2216318C2 (cs)
SI (1) SI1067904T1 (cs)
SK (1) SK284476B6 (cs)
TR (1) TR200002809T2 (cs)
TW (1) TWI233808B (cs)
UA (1) UA57615C2 (cs)
WO (1) WO1999049843A1 (cs)
ZA (1) ZA200005134B (cs)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2415643C (en) * 2000-07-17 2010-11-16 Yamanouchi Pharmaceutical Co., Ltd. Pharmaceutical composition for oral use with improved absorption
NZ534039A (en) * 2002-01-15 2006-08-31 Ucb Farchim S Formulations of pharmaceutical compositions for oral administration
IL164106A0 (en) * 2002-04-04 2005-12-18 Pfizer Prod Inc Palatable chewable tablet
ES2624585T3 (es) * 2004-05-28 2017-07-17 Imaginot Pty Ltd. Sistema de suministro de compuesto terapéutico oral
US8216610B2 (en) 2004-05-28 2012-07-10 Imaginot Pty Ltd. Oral paracetamol formulations
US20070020330A1 (en) * 2004-11-24 2007-01-25 Medpointe Healthcare Inc. Compositions comprising azelastine and methods of use thereof
US8758816B2 (en) * 2004-11-24 2014-06-24 Meda Pharmaceuticals Inc. Compositions comprising azelastine and methods of use thereof
KR20070104884A (ko) 2004-11-24 2007-10-29 메드포인트 헬쓰케어 인크. 아젤라스틴을 포함하는 조성물 및 이의 사용 방법
US20060198885A1 (en) * 2005-02-22 2006-09-07 Sun Pharmaceutical Industries Ltd. Oral pharmaceutical composition
AU2006317530B2 (en) * 2005-11-28 2011-09-01 Imaginot Pty Ltd Oral therapeutic compound delivery system
EP2344137B1 (en) * 2008-09-05 2015-12-02 Johnson & Johnson Consumer Inc. Method for making cetirizine tablets
CA2755543A1 (en) * 2009-03-13 2010-09-16 Nucitec S.A. De C.V. Compositions and methods for treatment and prevention of cardiovascular disease
WO2011146032A2 (en) * 2010-05-18 2011-11-24 Mahmut Bilgic Effervescent formulations
CN104363897A (zh) 2012-06-12 2015-02-18 宝洁公司 泡腾剂型
US20140371174A1 (en) 2013-06-12 2014-12-18 The Procter & Gamble Company Effervescent Dosage Form
JP5945191B2 (ja) * 2012-08-09 2016-07-05 株式会社ファンケル 口腔内速崩錠
JP6092672B2 (ja) * 2013-03-21 2017-03-08 株式会社ファンケル 口腔内速崩壊性錠剤
KR101591319B1 (ko) * 2013-12-03 2016-02-18 에프엔바이오 주식회사 홍삼 발포정의 제조방법
TW201605447A (zh) * 2014-06-20 2016-02-16 美林塔治療學有限公司 處理感染的方法
TWI732337B (zh) * 2014-06-20 2021-07-01 美商梅琳塔有限責任公司 醫藥組成物及其用途
EP3061501A1 (en) 2015-02-27 2016-08-31 Rottapharm Ltd. Composition for the treatment of acne
EP3117825A1 (en) 2015-07-16 2017-01-18 Rottapharm S.p.A. Oral formulation comprising berberine and morus alba extract
CN106109422A (zh) * 2016-07-28 2016-11-16 北京万全德众医药生物技术有限公司 盐酸左西替利嗪泡腾颗粒及其制备方法
US10624921B2 (en) 2016-11-15 2020-04-21 Berkeley Nox Limited Dietary supplements
JP2018108950A (ja) * 2016-12-28 2018-07-12 沢井製薬株式会社 レボセチリジン塩酸塩含有口腔内崩壊錠
WO2019099003A2 (en) * 2017-11-15 2019-05-23 Berkeley Nox Limited Novel dietary supplements
PT3799864T (pt) * 2019-10-02 2023-05-25 Intas Pharmaceuticals Ltd Composições farmacêuticas sólidas efervescentes essencialmente isentas de sódio
AU2021217209A1 (en) * 2020-02-03 2022-09-29 Kenvue Brands Llc A single layer chewable tablet comprising cetirizine
CN120437087A (zh) 2024-02-01 2025-08-08 科赴品牌有限责任公司 一种口腔溶解膜制剂、其用途及其制备方法

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI75816C (fi) * 1981-02-06 1988-08-08 Ucb Sa Foerfarande foer framstaellning av terapeutiskt aktiv 2-/4-(difenylmetyl)-1-piperazinyl/-aettiksyror eller dess amid.
US4678661A (en) * 1983-09-28 1987-07-07 Gerhard Gergely Effervescent composition and method of making same
US4792448A (en) * 1987-06-11 1988-12-20 Pfizer Inc. Generic zero order controlled drug delivery system
IL91398A (en) * 1988-08-30 1994-05-30 Pfizer Pharmaceutical delivery device comprising active substance surrounded by asymmetric membrane
US5178878A (en) 1989-10-02 1993-01-12 Cima Labs, Inc. Effervescent dosage form with microparticles
ES2067957T3 (es) * 1990-08-07 1995-04-01 Pfizer Uso de membranas polimerizadas interfacialmente en dispositivos de liberacion.
DK0584108T3 (da) * 1991-05-13 2000-10-09 Boots Co Plc Farmaceutisk præparat omfattende ibuprofensalt
GB9119052D0 (en) * 1991-09-06 1991-10-23 Boots Co Plc Pharmaceutical compositions
MX9300110A (es) * 1992-01-13 1994-07-29 Gerhard Gergely Preparacion farmaceutica en la forma de una tableta de efervescencia o de desintegracion o de un granulado de tipo instanteneo y procedimiento para su preparacion.
AU678561B2 (en) * 1992-10-09 1997-06-05 Procter & Gamble Company, The Pharmaceutical compositions and methods for treating cold symptoms
GB9224021D0 (en) * 1992-11-16 1993-01-06 Boots Co Plc Effervescent compositions
FR2698788B1 (fr) * 1992-12-09 1995-03-03 Union Pharma Scient Appl Composition pharmaceutique effervescente contenant de l'ibuprofène et son procédé de préparation.
TW401300B (en) * 1992-12-25 2000-08-11 Senju Pharma Co Antiallergic composition for ophthalmic or nasal use
EP0624364B1 (de) * 1993-04-15 1996-07-24 Gerhard Dr. Gergely Brausesystem mit einem alkali- und/oder metallempfindlichen, pharmazeutischen Wirkstoff, und Verfahren zur Herstellung
JPH08509725A (ja) * 1993-04-30 1996-10-15 ザ、プロクター、エンド、ギャンブル、カンパニー コートされた医薬組成物
US5458879A (en) * 1994-03-03 1995-10-17 The Procter & Gamble Company Oral vehicle compositions

Also Published As

Publication number Publication date
HK1036217A1 (en) 2001-12-28
NO20004722L (no) 2000-09-21
HUP0102676A3 (en) 2002-12-28
HUP0102676A2 (hu) 2001-11-28
CY1107331T1 (el) 2012-12-19
AU3925399A (en) 1999-10-18
RU2216318C2 (ru) 2003-11-20
WO1999049843A1 (de) 1999-10-07
UA57615C2 (uk) 2003-06-16
CA2326809C (en) 2008-11-18
TWI233808B (en) 2005-06-11
AR018828A1 (es) 2001-12-12
KR20010034718A (ko) 2001-04-25
NZ506988A (en) 2002-05-31
ATE209899T1 (de) 2001-12-15
IL138606A0 (en) 2001-10-31
PT1067904E (pt) 2002-05-31
BG104843A (en) 2001-07-31
NO20004722D0 (no) 2000-09-21
CN1295464A (zh) 2001-05-16
CZ20003481A3 (en) 2001-05-16
SK284476B6 (sk) 2005-04-01
SI1067904T1 (en) 2002-04-30
BG64741B1 (bg) 2006-02-28
ES2168013T3 (es) 2002-05-16
BR9909233A (pt) 2000-11-28
PL343199A1 (en) 2001-07-30
TR200002809T2 (tr) 2000-12-21
IL138606A (en) 2005-07-25
US6245353B1 (en) 2001-06-12
ZA200005134B (en) 2000-12-21
CZ300704B6 (cs) 2009-07-22
HU227477B1 (en) 2011-07-28
DE59900501D1 (de) 2002-01-17
EP1067904A1 (de) 2001-01-17
DK1067904T3 (da) 2002-04-02
AU750140B2 (en) 2002-07-11
PL191266B1 (pl) 2006-04-28
DE19814256A1 (de) 1999-10-07
CA2326809A1 (en) 1999-10-07
CN1136838C (zh) 2004-02-04
JP2002509873A (ja) 2002-04-02
SK14312000A3 (sk) 2001-07-10
EP1067904B1 (de) 2001-12-05
KR100653568B1 (ko) 2006-12-05

Similar Documents

Publication Publication Date Title
NO329071B1 (no) Faste, hurtig desintegrerende cetirizin-formuleringer
ES2462536T3 (es) Comprimido orodispersable multicapa
KR101020809B1 (ko) 펙소페나딘을 함유하는 구강 분산성 정제
US6242002B1 (en) Effervescent formulations
ES2229483T3 (es) Composiciones farmaceuticas para la liberacion controlada de sustancias activas.
US5880106A (en) Oral dosing formulations of dideoxy purine nucleosides
US20070082048A1 (en) Sleep aid formulations
AU2002364468B2 (en) Solid orally-dispersible pharmaceutical formulation
US20110300216A1 (en) Chewable, swallowable and effervescent solid dosage form for oral delivery of pharmaceutical actives
US20090202597A1 (en) Ache-Nmda Combination Wafer
WO1995003785A1 (en) Pleasant tasting effervescent cold/allergy medications
US7838029B1 (en) Mirtazapine solid dosage forms
WO2013098399A1 (en) Mozavaptan formulations
MXPA00009349A (en) Solid, quick dissolving cetirizine formulations
US20030228370A1 (en) Orodispersible solid pharmaceutical form
HK1036217B (en) Solid, quick dissolving cetirizine formulations

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees